Kreitman, R J <br/><br/>
Recombinant toxins containing the variable domains of the anti-Tac monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemia.  [electronic resource] 

 -  Blood  Nov 1992 
 - 2344-52 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADP Ribose Transferases<br/>Aged<br/>Antibodies, Monoclonal--pharmacology<br/>Bacterial Toxins<br/>Cell Survival--drug effects<br/>Exotoxins--genetics<br/>Female<br/>Humans<br/>Immunotoxins--pharmacology<br/>Leukemia, Lymphocytic, Chronic, B-Cell--blood<br/>Male<br/>Middle Aged<br/>Monocytes--drug effects<br/>Pseudomonas aeruginosa<br/>Receptors, Interleukin-2--immunology<br/>Recombinant Fusion Proteins--pharmacology<br/>Recombinant Proteins--pharmacology<br/>Tumor Cells, Cultured<br/>Virulence Factors<br/>Pseudomonas aeruginosa Exotoxin A